Navigation Links
Thomas Kipps receives ACGT Investigator Award
Date:4/20/2011

Citing his on-going development of an immune-mediated gene therapy for intractable B cell leukemia, the Alliance for Cancer Gene Therapy (ACGT) has awarded Thomas J. Kipps, MD, PhD, professor of medicine in the University of California, San Diego School of Medicine and deputy director of research operations at the UC San Diego Moores Cancer Center, its 2010 Investigator Award in Clinical Translation of Cell and Gene Therapy.

The award comes with a $750,000 grant spread over three years. Kipps had previously received a 2005 ACGT Investigator grant to conduct a phase 1 safety trial of the gene therapy approach.

Kipps, who holds the Evelyn and Edwin Tasch Chair in Cancer Research, specializes in chronic lymphocytic leukemia or CLL, the most common form of leukemia among adults in Western societies. CLL is currently considered incurable. More than 50 percent of relapsed CLL patients and 10 to 20 percent of newly diagnosed CLL patients have limited or no response to existing treatments, leading to a poor prognosis for survival.

Most therapy-resistant CLL patients exhibit a gene dysfunction on a particular chromosome. Current therapeutic options for these patients usually involve high-risk immunosuppressive treat-ments, which further reduces their lifespan. Kipps' alternative approach involves sensitizing leukemia cells to cell death (apoptosis), potentially making future treatments faster and more effective. Early research findings have been corroborated in vitro and in test patients who completed the proposed treatment course and achieved a complete response.

"There is a tremendous amount of new work that's going on to find the effective targets for gene therapy and also the delivery vehicles," said Kipps. "We're seeing some very encouraging results right now that are being translated into clinical trials."


'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert  

Page: 1

Related medicine news :

1. Thomas Jefferson University professor elected AAAS Fellow
2. Gala honors County Supervisor Mark Ridley-Thomas and businesswoman Anne-Merelie Murrell
3. Nationally Renowned Knee Specialist Dr. Thomas Meade Joins Coordinated Health
4. Thomas E. Heftler Migraine Research Award
5. Life Coach and Author Thomas Finn's Highly Anticipated Book, 'A Better Tomorrow- Affirmations and Visualizations the Keys to Success,' Debuts June 15
6. Thomas E. Mower Makes Generous Donations To Primary Children's Medical Center
7. Thomas E. Mower And Karl Malone Instrumental To Success Of Sportsmen For Fish And Wildlife Organization
8. Leading Orthopaedic Surgeon and Regenerative Medical Authority Dr. Thomas A. Einhorn Advances Adult Stem Cell Therapy To Eliminate Hip Replacement Surgery
9. Thomas J. Kent Jr. FDP Capital, LLC Chairman and Former NFL Player Jack Brewer Join Forces
10. Jenesse Salutes Husband and Wife Team, Supervisor Mark Ridley-Thomas and Avis Ridley-Thomas as 2010 Silver Rose Honorees
11. Dr. Hunter Handsfield wins prestigious Thomas Parran Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Thomas Kipps receives ACGT Investigator Award
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... working together to expand dental health services to the developmentally disabled in the ... Care Dental’s operations to a new facility at 71-949 Highway 111, Suite 100-B, ...
(Date:2/10/2016)... ... February 10, 2016 , ... InDemand Interpreting , ... recently partnered with Heart City Health Center to improve access to ... Heart City Health Center has provided the Elkhart community with access to high ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... charity program created to assist the local community. Pledging to select a new ... nonprofit organizations in the area. Their goal is to bring community awareness to ...
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. ... office is now offering a variety of comprehensive procedures for facial enhancement. The ... facial volume restoration, lip enhancement and nasal reshaping. , As a result, ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s 2016 Executive Forum, ... 200 of the country’s top healthcare executives to share insights on transformational strategies ... the Forum is the provider-centric perspective, experience, expertise and strategy shared by the ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- Urologix, the market leader for in-office minimally invasive ... (BPH), announces new private ownership and is operating as ... industry veteran of more than 20 years, has been ... Plymouth, Minn. The company,s two ... RF Therapy, will continue to be broadly available and ...
(Date:2/10/2016)... Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC Markets: ... 1-for-100 reverse split of its issued and outstanding shares ... on Thursday, February 11, 2016. The Company,s common stock ... number 76303T308 and temporary ticker symbol "RCHAD". After 20 ... the ticker symbol (RCHA).  --> ...
(Date:2/10/2016)... 10, 2016  Oxis International Inc. (OTC/QB: OXIS) announced ... described as a "clinical trial triumph" after one of ... complete cancer remission. Daniel Vallera , ... Cancer Center. --> Daniel Vallera , ... Cancer Center. --> An article on ...
Breaking Medicine Technology: